Vikram Thermo (India) Ltd
Incorporated in 1985, Vikram Thermo
Ltd manufactures and sells basic pharma
co-polymers[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FOB Value of Exports Rs. in lakhs ・Standalone data |
|
||||||||||
| Permanent Employees count ・Standalone data |
|||||||||||
| R&D Expenditure (% of Total Revenue) % ・Standalone data |
|||||||||||
| Export Revenue Share (% of Total Revenue) % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for INTIMATION OF BOARD MEETING UNDER REGULATION 29(1)(A) OF SEBI (LODR) REGULATIONS 2015.
- Board meeting on 4 November 2026 to approve Q2 FY2027 unaudited results; trading window closed till 6 November.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Regulation 74(5) certificate for quarter ended 30 September 2026 confirms demat requests processed.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM on 29 Sep 2026 approved reappointment of two Whole Time Directors and related-party remuneration increase.
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Vikram Thermo disclosed 32nd AGM voting results; all seven resolutions passed on 29 September 2026.
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
VTL is an ISO 9001, DRCOAT, and
EXCiPACT International is a GMP-certified, integrated, research-based pharmaceutical excipient company. It manufactures, markets, and exports pharmaceutical excipients and chemicals.